Dr. Christopher Morrison, M.D

Gastroenterology Voorhees, NJ Male
NPI: 1548581473
Total Payments
$7,129
2024 Payments
$1,983
Companies
36
Transactions
440
Medicare Patients
4,867
Medicare Billing
$689,303

Payment Breakdown by Category

Food & Beverage$7,092 (99.5%)
Education$36.98 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,092 438 99.5%
Education $36.98 2 0.5%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,803 116 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $846.29 58 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $689.17 46 $0 (2024)
Janssen Biotech, Inc. $470.00 31 $0 (2024)
Merck Sharp & Dohme LLC $254.12 18 $0 (2024)
Celgene Corporation $241.63 16 $0 (2024)
IRONWOOD PHARMACEUTICALS, INC $221.80 14 $0 (2024)
Takeda Pharmaceuticals America, Inc. $207.99 21 $0 (2017)
Synergy Pharmaceuticals Inc $196.30 16 $0 (2018)
PFIZER INC. $180.52 12 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,983 107 ABBVIE INC. ($429.77)
2023 $1,573 104 ABBVIE INC. ($603.58)
2022 $923.12 56 ABBVIE INC. ($335.63)
2020 $297.51 11 ERBE USA Inc ($130.50)
2019 $740.13 46 Takeda Pharmaceuticals U.S.A., Inc. ($241.75)
2018 $1,059 71 Takeda Pharmaceuticals U.S.A., Inc. ($234.85)
2017 $552.39 45 Takeda Pharmaceuticals America, Inc. ($207.99)

All Payment Transactions

440 individual payment records from CMS Open Payments — Page 18 of 18

Date Company Product Nature Form Amount Type
04/12/2017 Takeda Pharmaceuticals America, Inc. Dexilant (Drug) Food and Beverage In-kind items and services $4.80 General
Category: Upper GI
04/05/2017 Takeda Pharmaceuticals America, Inc. Dexilant (Drug) Food and Beverage In-kind items and services $9.24 General
Category: Upper GI
04/03/2017 Allergan Inc. VIBERZI (Drug) Food and Beverage In-kind items and services $13.35 General
Category: GASTROENTEROLOGY
04/01/2017 Daiichi Sankyo Inc. Movantik (Drug) Food and Beverage In-kind items and services $18.64 General
Category: Opioid Induced Constipation
03/28/2017 Intercept Pharmaceuticals, Inc. OCA (Drug) Food and Beverage In-kind items and services $12.56 General
Category: Gastroenterology
03/08/2017 Takeda Pharmaceuticals America, Inc. Amitiza (Drug) Food and Beverage In-kind items and services $10.52 General
Category: Lower GI
03/06/2017 Ironwood Pharmaceuticals, Inc LINZESS (Drug), VIBERZI, DELZICOL Food and Beverage In-kind items and services $14.96 General
Category: Gastroenterology
02/22/2017 Takeda Pharmaceuticals America, Inc. Amitiza (Drug) Food and Beverage In-kind items and services $14.82 General
Category: Lower GI
02/15/2017 Janssen Biotech, Inc. STELARA (Biological), REMICADE, SIMPONI Food and Beverage In-kind items and services $11.36 General
Category: Immunology
02/06/2017 Takeda Pharmaceuticals America, Inc. Amitiza (Drug) Food and Beverage In-kind items and services $9.18 General
Category: Lower GI
01/31/2017 Allergan Inc. VIBERZI (Drug) Food and Beverage In-kind items and services $15.73 General
Category: GASTROENTEROLOGY
01/30/2017 Takeda Pharmaceuticals America, Inc. Entyvio (Biological) Food and Beverage In-kind items and services $12.34 General
Category: Lower GI
01/25/2017 Janssen Biotech, Inc. STELARA (Biological), REMICADE, SIMPONI Food and Beverage In-kind items and services $11.36 General
Category: Immunology
01/25/2017 Allergan Inc. LINZESS (Drug) Food and Beverage In-kind items and services $10.75 General
Category: GASTROENTEROLOGY
01/20/2017 Takeda Pharmaceuticals America, Inc. Amitiza (Drug) Food and Beverage In-kind items and services $8.86 General
Category: Lower GI
«1…161718

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 17 890 34,549 $1.3M $356,367
2022 18 1,180 1,258 $554,331 $98,713
2021 19 1,495 1,614 $733,350 $123,303
2020 17 1,302 1,438 $625,900 $110,921
Total Patients
4,867
Total Services
38,859
Medicare Billing
$689,303
Procedure Codes
71

All Medicare Procedures & Services

71 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J3380 Injection, vedolizumab, 1 mg Office 2023 23 14,100 $719,100 $243,849 33.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 163 185 $52,540 $18,910 36.0%
J1439 Injection, ferric carboxymaltose, 1 mg Office 2023 20 19,500 $58,500 $17,127 29.3%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 78 78 $105,753 $16,966 16.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 102 102 $37,230 $11,522 30.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 100 108 $21,600 $7,666 35.5%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 32 67 $29,949 $6,874 23.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 58 59 $17,169 $6,399 37.3%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 55 83 $13,463 $5,472 40.6%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 68 70 $70,195 $5,117 7.3%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 56 56 $74,680 $3,511 4.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 49 49 $12,054 $3,372 28.0%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 23 23 $22,782 $2,759 12.1%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 12 12 $12,840 $2,207 17.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 13 13 $5,590 $1,879 33.6%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 23 29 $6,960 $1,637 23.5%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 15 15 $10,497 $1,101 10.5%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 120 120 $154,665 $22,914 14.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 143 143 $54,995 $17,051 31.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 200 245 $43,175 $14,655 33.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 148 155 $39,931 $12,896 32.3%
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope Facility 2022 43 49 $38,710 $5,587 14.4%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 79 80 $60,510 $5,427 9.0%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 52 52 $58,220 $4,094 7.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 38 38 $11,928 $3,993 33.5%
123»

About Dr. Christopher Morrison, M.D

Dr. Christopher Morrison, M.D is a Gastroenterology healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1548581473.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Morrison, M.D has received a total of $7,129 in payments from pharmaceutical and medical device companies, with $1,983 received in 2024. These payments were reported across 440 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,092).

As a Medicare-enrolled provider, Morrison has provided services to 4,867 Medicare beneficiaries, totaling 38,859 services with total Medicare billing of $689,303. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Other Specialties Gastroenterology
  • Location Voorhees, NJ
  • Active Since 06/15/2010
  • Last Updated 10/08/2024
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1548581473

Products in Payments

  • XIFAXAN (Drug) $486.60
  • RINVOQ (Biological) $441.33
  • LINZESS (Drug) $378.90
  • ENTYVIO (Biological) $355.48
  • STELARA (Biological) $312.37
  • Amitiza (Drug) $270.63
  • ZEPOSIA (Drug) $261.12
  • Entyvio (Biological) $258.02
  • Humira (Biological) $247.42
  • DUPIXENT (Biological) $239.72
  • VIBERZI (Drug) $231.57
  • SKYRIZI (Biological) $198.00
  • Trulance (Drug) $196.30
  • ZENPEP (Drug) $177.19
  • DIFICID (Drug) $172.92
  • Linzess (Drug) $168.35
  • HUMIRA (Biological) $153.60
  • RELTONE 200 MG (Drug) $150.00
  • TRULANCE (Drug) $139.75
  • XELJANZ (Drug) $138.72

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Voorhees

Dr. Sanket Patel, D.o, D.O

Gastroenterology — Payments: $39,650

Gastroenterology $39,650

Dr. Alan Mushnick, Md, MD

Gastroenterology — Payments: $26,516

Gastroenterology $26,516

Elizabeth Egan, Md, MD

Gastroenterology — Payments: $10,600

Gastroenterology $10,600

Dr. Michael Goldstein, Md, MD

Gastroenterology — Payments: $10,508

Gastroenterology $10,508

Alex Celluzzi, Do, DO

Gastroenterology — Payments: $9,192

Gastroenterology $9,192

Andrew Alloy, Do, DO

Gastroenterology — Payments: $9,041

Gastroenterology $9,041